Article info
PDFHepatology
Original article
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
- Correspondence to Dr Jelena Mann, Fibrosis Laboratories, Institute of Cellular Medicine, 4th floor, William Leech Bldg., Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; jelena.mann{at}ncl.ac.uk
Citation
Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
Publication history
- Received January 25, 2016
- Revised February 23, 2016
- Accepted February 27, 2016
- First published March 21, 2016.
Online issue publication
June 06, 2017
Article Versions
- Previous version (21 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/